China methyl)isonicotinohydrazide Factory

We believe in: Innovation is our soul and spirit. Quality is our life. Shopper need is our God for methyl)isonicotinohydrazide,CAS NO 1841081-71-7,1841081-71-7,Topiroxostat intermediate,Topiroxostat advance intermediate, To acquire a consistent, profitable, and constant development by getting a aggressive advantage, and by continuously increasing the value added to our shareholders and our employee.
methyl)isonicotinohydrazide, We welcome an opportunity to do business with you and hope to have pleasure in attaching further details of our products. Excellent quality, competitive price, punctual delivery and dependable service can be guaranteed. For further inquires be sure to do not hesitate to contact us.

Hot Products

  • Micafungin sodium

    Micafungin sodium

    Product Name:Micafungin sodium
    Molecular Formula:C56H72N9NaO23S
    Molecular Weight;1294.28
    CAS Registry Number;208538-73-2
  • D-Ribose

    D-Ribose

    Product Name:D-Ribose
    Molecular Formula:C5H10O5
    Molecular Weight:150.13
    CAS Registry Number:50-69-1
  • Cinnamyl Acetoacetate

    Cinnamyl Acetoacetate

    Product Name:Cinnamyl Acetoacetate
    Molecular Formula:C13H14O3
    Molecular Weight:218.25
    CAS Registry Number:57582-46-4
  • Clopidogrel

    Clopidogrel

    Product Name:Clopidogrel
    Molecular Formula:C16H16ClNO2S
    Molecular Weight;321.82
    CAS Registry Number;113665-84-2
  • 2-Fluorobenzoyl chloride

    2-Fluorobenzoyl chloride

    Product Name:2-Fluorobenzoyl chloride
    Molecular Formula:C7H4ClFO
    Molecular Weight:158.56
    CAS Registry Number:393-52-2
  • Tert-Butyl 4-(6-Amino-3-pyridyl)piperazine-1-carboxylate

    Tert-Butyl 4-(6-Amino-3-pyridyl)piperazine-1-carboxylate

    Product Name:Tert-Butyl 4-(6-Amino-3-pyridyl)piperazine-1-carboxylate
    Molecular Formula:C14H22N4O2
    Molecular Weight:278.35
    CAS Registry Number:571188-59-5

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept